DOCSLIB.ORG

Demystifying the Placebo Effect

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Demystifying the Placebo Effect City University of New York (CUNY) CUNY Academic Works All Dissertations, Theses, and Capstone Projects Dissertations, Theses, and Capstone Projects 9-2018 Demystifying the Placebo Effect Phoebe Friesen The Graduate Center, City University of New York How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/gc_etds/2775 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] DEMYSTIFYING THE PLACEBO EFFECT by PHOEBE FRIESEN A dissertation submitted to the Graduate Faculty in Philosophy in partial fulfillment of the requirements for the degree of Doctor of Philosophy, The City University of New York 2018 © 2018 PHOEBE FRIESEN All Rights Reserved ii Demystifying the Placebo Effect by Phoebe Friesen This manuscript has been read and accepted for the Graduate Faculty in Philosophy in satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. ___________ ____________________________________ Date [Peter Godfrey-Smith] Chair of Examining Committee ___________ ____________________________________ Date [Nickolas Pappas ] Executive Office Supervisory Committee: Peter Godfrey-Smith Jesse Prinz John Greenwood THE CITY UNIVERSITY OF NEW YORK iii ABSTRACT Demystifying the Placebo Effect by Phoebe Friesen Advisor: Peter Godfrey-Smith This dissertation offers a philosophical analysis of the placebo effect. After offering an overview of recent evidence concerning the phenomenon, I consider several prominent accounts of the placebo effect that have been put forward and argue that none of them are able to adequately account for the diverse instantiations of the phenomenon. I then offer a novel account, which suggests that we ought to think of the placebo effect as encompassing three distinct responses: conditioned placebo responses, cognitive placebo responses, and network placebo responses. Next, I consider implications of the placebo effect’s role in complementary and alternative medicine for discussions of how to demarcate between science and pseudoscience within philosophy of science. Finally, I offer a bioethical argument that maintains that the neglect of the placebo effect within medicine may be contributing to an increase in health disparities along lines of race and ethnicity. iv Table of Contents Introduction ............................................................................................................................... 1 Chapter 1. The Ubiquitous Placebo Effect: Evaluating Accounts Alongside Evidence ....................................................................................................................................... 5 I. Introduction .................................................................................................................................. 5 II. Traditional Roles of the Placebo in Research and Practice .............................................. 5 III. What We Have Learned About the Placebo Effect............................................................. 8 IIIa. Examples of the Placebo Effect ......................................................................................................... 8 IIIb. Placebo Mechanisms .......................................................................................................................... 10 IIIc. Individuality and Placebo Reponses .............................................................................................. 13 IIId. Revisiting the Two Roles of the Placebo Effect ........................................................................ 14 IV. Accounts of the Placebo Effect .............................................................................................. 15 IVa. The Outcome of the Placebo Arm .................................................................................................. 15 IVb. The Placebo as Inert ........................................................................................................................... 16 IVc. The Placebo as Non-Specific ........................................................................................................... 16 IVc1. Non-specific Mechanisms ............................................................................................................................ 17 IVc2. Non-specific Effects ....................................................................................................................................... 18 IVc3. Non-specific Treatments ............................................................................................................................... 19 IVd. The Placebo as Psychological ......................................................................................................... 21 IVe. The Placebo as Incidental ................................................................................................................. 24 V. The Placebo as Mediated by Meaning and Context ......................................................... 27 VI. Conclusion .................................................................................................................................. 29 Chapter 2. An Account of the Placebo Effect: Conditioned, Cognitive, and Network Placebo Responses .............................................................................................. 30 I. Introduction ............................................................................................................................... 30 II. The Goals of an Account of the Placebo Effect ................................................................. 30 III. Conditioned, Cognitive, and Network Placebo Responses ............................................. 34 IIIa. Conditioned Placebo Responses ..................................................................................................... 35 IIIb. Cognitive Placebo Responses .......................................................................................................... 38 IIIc. Network Placebo Responses ............................................................................................................ 41 v IV. Returning to the Three Goals ................................................................................................ 46 IVa. Demarcation .......................................................................................................................................... 46 IVb. Explanation ........................................................................................................................................... 47 IVc. Direction ................................................................................................................................................. 49 V. Conclusion .................................................................................................................................. 51 Chapter 3. Expanding The Demarcation Project: Protoscience, the Placebo Effect, and Complementary and Alternative Medicine ............................................. 53 I. Introduction ............................................................................................................................... 53 II. Placebo Responses within Complementary and Alternative Medicine ....................... 56 IIa. Features of CAM Practices ................................................................................................................ 57 IIb. Practitioner Views on the Placebo Effect ...................................................................................... 58 IIc. Conditions Commonly Treated within CAM ............................................................................... 59 IIId. Homeopathy .......................................................................................................................................... 60 III. CAM as Pseudoscience? ......................................................................................................... 61 IIIa. A Meaningful Difference .................................................................................................................. 61 IIIc. Diversity of CAM Practices ............................................................................................................. 62 IIIc. Capturing Distinctions ....................................................................................................................... 65 IV. Theories of Demarcation ........................................................................................................ 65 IVa. Theory as the Criterion of Demarcation ....................................................................................... 66 IVb. Practice as the Criterion of Demarcation ..................................................................................... 68 IVc. Critical Attitudes as the Criterion of Demarcation ................................................................... 69 IVd. Pluralist Theories of Demarcation ................................................................................................. 71 V. CAM as Protoscience............................................................................................................... 73 Va. Protoscience in Discussions of Demarcation ..............................................................................
Load more

Recommended publications
  • Potential of a Fly Gut Microbiota Incorporated Gel-Based Larval Diet for Rearing Bactrocera Dorsalis (Hendel) Mahfuza Khan1*, Kajla Seheli1, Md
    Khan et al. BMC Biotechnology 2019, 19(Suppl 2):94 https://doi.org/10.1186/s12896-019-0580-0 RESEARCH Open Access Potential of a fly gut microbiota incorporated gel-based larval diet for rearing Bactrocera dorsalis (Hendel) Mahfuza Khan1*, Kajla Seheli1, Md. Abdul Bari1, Nahida Sultana1, Shakil Ahmed Khan1, Khandokar Fahmida Sultana2 and Md. Anwar Hossain3 Abstract Background: The Oriental fruit fly, Bactrocera dorsalis (Hendel) (Diptera: Tephritidae), is an important polyphagous pest of horticultural produce. The sterile insect technique (SIT) is a proven control method against many insect pests, including fruit flies, under area-wide pest management programs. High quality mass-rearing process and the cost-effective production of sterile target species are important for SIT. Irradiation is reported to cause severe damage to the symbiotic community structure in the mid gut of fruit fly species, impairing SIT success. However, studies have found that target-specific manipulation of insect gut bacteria can positively impact the overall fitness of SIT-specific insects. Results: Twelve bacterial genera were isolated and identified from B. dorsalis eggs, third instars larval gut and adults gut. The bacterial genera were Acinetobacter, Alcaligenes, Citrobacter, Pseudomonas, Proteus, and Stenotrophomonas, belonging to the Enterobacteriaceae family. Larval diet enrichment with the selected bacterial isolate, Proteus sp. was found to improve adult emergence, percentage of male, and survival under stress. However, no significant changes were recorded in B. dorsalis egg hatching, pupal yield, pupal weight, duration of the larval stage, or flight ability. Conclusions: These findings support the hypothesis that gut bacterial isolates can be used in conjunction with SIT.
    [Show full text]
  • Homeopathy and Psychological Therapies
    Entry Homeopathy and Psychological Therapies Davide Donelli * and Michele Antonelli AUSL-IRCCS Reggio Emilia, 42122 Reggio Emilia, Italy; [email protected] * Correspondence: [email protected] Definition: Homeopathy is a popular, although highly debated, medicinal practice based on the administration of remedies in which active substances are so diluted that no detectable trace of them remains in the final product. This hypothesis paper aims to outline a possible reinterpreta- tion of homeopathy in the light of psychological therapies in order to improve its clinical safety and sustainability. Keywords: homeopathy; psychology; reinterpretation; hypothesis 1. Introduction Homeopathy is a popular, although highly debated, medicinal practice. In Italy, for ex- ample, it is estimated that, even if with a slightly declining trend, around 4.1% of the entire population (almost 2.5 million people) occasionally or regularly seeks homeopathic care, and these data, collected in 2013, suggest that homeopathy is the most used Complemen- tary and Alternative Medicine (CAM) by Italians [1]. Epidemiological studies aimed to assess the worldwide prevalence of homeopathy use have reported similar data for other high-income countries [2]. Homeopathy was first invented by the German doctor Samuel Hahnemann (1755–1843), and it is based on the administration of remedies in which active substances are so diluted that no detectable trace of them remains in the final product [3]. In his empirical studies, Citation: Donelli, D.; Antonelli, M. Hahnemann reported that the self-administration of a common antimalarial medicinal Homeopathy and Psychological Ther- plant (Cinchona) resulted in the occurrence of the same symptoms of malaria, but to a Encyclopedia 2021 1 apies.
    [Show full text]
  • Philosophy, Science, Antiscience the Institute of Philosophy Summer School 2020 Zagreb, 15-17 June 2020
    Philosophy, Science, Antiscience The Institute of Philosophy Summer School 2020 Zagreb, 15-17 June 2020 MONDAY 9.30-10.00 Registration 10.00-13.00 Course 1 Dr. Luka Boršić (Institute of Philosophy, Zagreb) Anti-Aristotelianism and the Emergence of Modern Science 13.00-16.00 Break 16.00-19.00 Course 2 Professor Robert J. Hankinson (University of Texas at Austin) Physics, Mathematics, and Explanation in Aristotle TUESDAY 10.00-13.00 Course 3 Dr. Ivana Skuhala Karasman (Institute of Philosophy, Zagreb) Astrology: From Science to Pseudoscience 13.00-15.00 Break 15.00-18.00 Course 4 Professor Jure Zovko (Institute of Philosophy, Zagreb / University of Zadar) Does Relativism Threaten the Sciences? WEDNESDAY 10.00-13.00 Course 5 Dr. Marija Brajdić Vuković (Institute of Social Research, Zagreb) What is an Expert? Scientific and Public Controversies 13.00-15.00 Break 15.00-18.00 Course 6 Professor Luca Malatesti (University of Rijeka) Science in the Courtroom. Some Conceptual and Methodological Issues in Transferring Neuropsychological Science in the Insanity Defence 18:00-18:30 Break 1 18.30-20.00 Closing Lecture Professor Darko Polšek (Department of Anthropology, Faculty of Humanities and Social Sciences, Zagreb) Science: Good, Bad and Bogus (New Challenges!) 2 COURSE 1 Anti-Aristotelianism and the Emergence of Modern Science INSTRUCTOR Dr. Luka Boršić (Institute of Philosophy, Zagreb) ABSTRACT We are going to inquire into the changes of paradigm that happened notably in the 16th century and which prepared the ground for the emergence of modern science. In more detail we are going to explore the texts of three Renaissance philosophers: Mario Nizolio (De veris principiis), Frane Petrić (Francesco Patrizi, Discussiones peripateticae) and Jacopo Mazzoni (In universam Platonis et Aristotelis philosophiam praeludia).
    [Show full text]
  • Ocps) Used in the NM Family Planning Program (FPP
    The following slides are intended to familiarize nurses and clinicians with oral contraceptive pills (OCPs) used in the NM Family Planning Program (FPP). The FPP does not intend for this information to supersede the Family Planning Protocol particularly on the requirement for Public Health Nurses in the Public Health Offices to consult a clinician as stated in the Protocol when in doubt or if it is necessary to switch the client’s OCP type. 1 2 Combined oral contraceptives (COCs) contain two hormones; estrogen and progestin. In general, any combined OCP is good for most women who are eligible to take estrogen according to the CDC U.S. Medical Eligibility Criteria (MEC). Once again, refer to the US MEC chart to find out if OCP is a suitable choice for clients with specific health conditions. To learn a little bit about what each hormone does, the FPP is providing the following summary: Estrogen: provides endometrial stability = menstrual cycle control. A higher estrogen dose increases the venous thromboembolism (VTE) or clot risk but OCP clot risk is still less harmful than the clot risk related to pregnancy and giving birth. Progestin: provides most of the contraceptive effect by ‐Preventing luteinizing hormone (LH) surge /ovulation ‐Thickening the cervical mucus to prevent sperm entry. Two major OCP formations are available. Monophasic: There is only one dose of estrogen and progestin in each active pill in the packet; and Multiphasic: There are varying doses of hormones, particularly progestin in the active pills. 3 Section 3 of the FPP Protocol contains the OCP Substitute Table, which groups OCPs into 6 classes according to the estrogen dosage, the type of progestin and the formulations.
    [Show full text]
  • Nicotine and Behavioral Markers of Risk for Schizophrenia: a Double-Blind, Placebo- Controlled, Cross-Over Study Lana Dépatie, M.Sc., Gillian A
    Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo- Controlled, Cross-Over Study Lana Dépatie, M.Sc., Gillian A. O’Driscoll, Ph.D., Anne-Lise V. Holahan, B.Sc., Victoria Atkinson, R.N., Joseph X. Thavundayil, M.D., N. Ng Ying Kin, Ph.D., and Samarthji Lal, M.D. We investigated the effect of nicotine on three behavioral groups. A Drug ϫ Monitoring condition interaction (p Ͻ .01) markers of risk for schizophrenia: sustained attention on pursuit gain indicated that nicotine significantly (using the Continuous Performance Task (CPT)), increased pursuit gain in the no-monitoring condition in antisaccade performance, and smooth pursuit. Smooth patients and controls equally, but did not improve pursuit pursuit was investigated in two conditions, one in which in the monitoring condition. Thus, improvement in pursuit attention was enhanced (monitoring target changes) and may have been mediated via an effect on attention rather one in which attention was not enhanced (no monitoring). than by an effect on oculomotor function per se. In patients, Patients with schizophrenia (n ϭ 15) and controls (n ϭ 14) the magnitude of improvement in attention on nicotine was were given a 14-mg nicotine patch in a double-blind, correlated with the improvement on eye movement tasks. placebo-controlled, crossover design and plasma nicotine Thus, nicotine improves performance on both attention and concentrations were monitored. Nicotine concentrations oculomotor markers of risk for schizophrenia, possibly via were similar in both groups. A Group ϫ Drug interaction common mechanisms. (p Ͻ .02) on CPT hits indicated that nicotine improved [Neuropsychopharmacology 27:1056–1070, 2002] sustained attention in patients but not in controls.
    [Show full text]
  • Placebo-Controlled Trials of New Drugs: Ethical Considerations
    Reviews/Commentaries/Position Statements COMMENTARY Placebo-Controlled Trials of New Drugs: Ethical Considerations DAVID ORENTLICHER, MD, JD als, placebo controls are not appropriate when patients’ health would be placed at significant risk (8–10). A placebo- controlled study for a new hair- uch controversy exists regarding sufficiently more effective than placebo to thickening agent could be justified; a the ethics of placebo-controlled justify its use. Finally, not all established placebo-controlled study for patients M trials in which an experimental therapies have been shown to be superior with moderate or severe hypertension therapy will compete with an already es- to placebo. If newer drugs are compared would not be acceptable (11). Similarly, if tablished treatment (or treatments). In with the unproven existing therapies, an illness causes problems when it goes such cases, argue critics, patients in the then patients may continue to receive untreated for a long period of time, a 52- control arm of the study should receive an drugs that are harmful without being week study with a placebo control is accepted therapy rather than a placebo. helpful. much more difficult to justify than a By using an active and effective drug, the Moreover, say proponents of placebo 6-week study (12). control patients would not be placed at controls, patients can be protected from When David S.H. Bell (13) explains risk for deterioration of their disease, and harm by “escape” criteria, which call for why placebo controls are unacceptable the study would generate more meaning- withdrawal from the trial if the patient for new drugs to treat type 2 diabetes, he ful results for physicians.
    [Show full text]
  • A Comparative Anatomical Investigation of Three Taxa of Brassica L
    Bangladesh J. Plant Taxon. 27(1): 15‒26, 2020 (June) © 2020 Bangladesh Association of Plant Taxonomists A COMPARATIVE ANATOMICAL INVESTIGATION OF THREE TAXA OF BRASSICA L. FROM BANGLADESH FARIA AKBAR AND KAZI NAHIDA BEGUM* Department of Botany, Faculty of Life and Earth Sciences, Jagannath University, Dhaka-1100, Bangladesh Key words: Brassica L.; Root anatomy; Stem anatomy; Stomata; Trichome. Abstract In the present study, micromorphology and comparative anatomy of young root, stem and leaf of three economically important taxa of Brassica L. viz., B. rapa L. subsp. campestris (L.) Clapham, B. juncea (L.) Czern. and B. napus L. are investigated in detail for the first time in Bangladesh by using light microscopy (LM). In anatomical studies, cross sections of young root, stem and leaf have been examined and biometric measurement of cell and tissues are presented. The micromorphological studies are related to the epidermal surface. In addition, the stomatal index and stomatal index ratio of these taxa have been calculated and presence of simple, non-glandular, unicellular trichome on stems and leaves also been observed except on the stem of B. rapa L. subsp. campestris (L.) Clapham. The anatomical study reveals that the investigated taxa have primary growth in roots and stems as well as amphistomatic and bifacial leaves with anisocytic stomata have been noticed. Finally, presence of tetrarch or single strand exarch xylem in vascular bundle of root, the size, shape and presence or absence of trichome over stem, shape of midrib of leaf have been considered to provide reliable features for identification of the Brassica species. Introduction The family Brassicaceae consists of 338 genera and 3709 species and dispersed all through the world, basically in temperate regions of the Northern Hemisphere (Warwick et al., 2006; Kasem et al., 2011).
    [Show full text]
  • Homeopathy Is Marketed As a Safe, Natural and Holistic Treatment for a Range of Ailments and Illnesses, Including Another Way of Saying
    sense about... sense about... sense about... sense about... sense about... sense about...Homeo sense about... sense about...path sense about...yyy sense about... sense about... sense about... sense about... sense about... sense about... sense about... Homeopathy is marketed as a safe, natural and holistic treatment for a range of ailments and illnesses, including Another way of saying... arthritis, asthma, depression, eczema, diarrhoea, hayfever, 8lacebo 999 a prescription that is inert; that is, it does nothing, headaches, insomnia and toothache. Homeopathic products and like a sugar pill or water. From the Latin, 1 will please.) services have become a large industry. 8lacebo effect 9 an effect, biological, biochemical or Despite this, it has not been embraced by medical science. The physiological, that emerges from an inert treatment because scientific evidence shows that homeopathy acts only as a the patient believes it will work. See page 2 for how placebos work.) placebo and there is no scientific explanation of how it could work any other way. Not to be confused... HomeoHomeopathpathpathicic principles 8roven 999 0proving( is the method homeopaths use to determine the symptoms a substance causes with a view to Homeopathy is based on two beliefs: 1) like cures like; and 2) treating diseases with similar symptoms); after the process a the smaller the dose the more potent the cure. First, homeopaths substance is said to be 0proven(. Scientists use 0proven( to choose a substance that causes the same symptoms as the describe a statement that is, by logic, necessarily true. disease they want to treat. For example, the runny nose and watery eyes of a cold can be recreated by inhaling onion fumes, human and animal waste, dead plants, bacteria and minerals; it so onion juice can form the basis of a homeopathic preparation.
    [Show full text]
  • Identification of Genes Influencing Wood Fibre Properties in Eucalyptus Nitens
    Identification of genes influencing wood fibre properties in Eucalyptus nitens By Nahida Bhuiyan B. Sc Ag (Hons 1); Master of Horticulture Thesis submitted in total fulfillment of the requirements for the degree of Doctor of Philosophy School of Forest and Ecosystem Science The University of Melbourne May 2008 Abstract Eucalypts are a major forest resource globally and the area of eucalypt plantations for pulp and paper production is expanding rapidly in Australia. Consequently, there is an increasing need to breed eucalypts with improved wood properties. Since many high value wood traits are under strong genetic control, identification of DNA markers linked to these traits will have application in breeding programs. In recent years there has been a shift in marker strategy away from QTL mapping in pedigrees to association studies in unrelated populations. In the latter approach, single nucleotide polymorphisms (SNPs) in candidate genes are screened to identify SNPs that significantly associate with wood traits. Significant SNPs could be used for marker-assisted selection (MAS) in breeding programs. The objectives of this study were to identify candidate genes that may influence pulp yield in eucalypts and to identify SNP variants in those genes that associate with superior wood and pulp traits. Approximately 300 trees from a full-sib Eucalyptus nitens progeny derived from a wide intra specific cross were used for gene discovery. DNA microarrays containing ~5800 young xylem of cDNAs Eucalyptus grandis were screened with probes synthesised from RNA isolated from trees with either high or low pulp yield. Forty-six transcripts were differentially regulated, of which 27 were more abundant in high pulp trees and 19 were more abundant in low pulp trees.
    [Show full text]
  • Medicinal Plants with Anti-Leukemic Effects: a Review
    molecules Review Medicinal Plants with Anti-Leukemic Effects: A Review Tahani Maher 1 , Raha Ahmad Raus 1, Djabir Daddiouaissa 1,2 , Farah Ahmad 1 , Noor Suhana Adzhar 3, Elda Surhaida Latif 4, Ferid Abdulhafiz 5 and Arifullah Mohammed 5,* 1 Biotechnology Engineering Department, Kulliyyah of Engineering, International Islamic University, Malaysia (IIUM), P.O. Box 10, Gombak, Kuala Lumpur 50728, Malaysia; [email protected] (T.M.); [email protected] (R.A.R.); [email protected] (D.D.); [email protected] (F.A.) 2 International Institute for Halal Research and Training (INHART), Level 3, KICT Building, International Islamic University Malaysia (IIUM), Jalan Gombak, Kuala Lumpur 53100, Malaysia 3 Faculty of Industrial Sciences and Technology, Universiti Malaysia, Pekan Pahang, Kuantan 26600, Malaysia; [email protected] 4 Centre for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia; [email protected] 5 Faculty of Agro-Based Industry, Universiti Malaysia Kelantan, Jeli, Kelantan 17600, Malaysia; [email protected] * Correspondence: [email protected] Abstract: Leukemia is a leukocyte cancer that is characterized by anarchic growth of immature immune cells in the bone marrow, blood and spleen. There are many forms of leukemia, and the best course of therapy and the chance of a patient’s survival depend on the type of leukemic disease. Different forms of drugs have been used to treat leukemia. Due to the adverse effects associated Citation: Maher, T.; Ahmad Raus, R.; with such therapies and drug resistance, the search for safer and more effective drugs remains Daddiouaissa, D.; Ahmad, F.; Adzhar, one of the most challenging areas of research.
    [Show full text]
  • Placebo As a Treatment for Depression Walter A
    NEUROPSYCHOPHARMACOLOGY 1994-VOL. 10, NO.4 265 REVIEW AND COMMENTARIES Placebo as a Treatment for Depression Walter A. Brown, M.D. The placebo response rate in depression consistently falls the psychotherapies (expectation of improvement, between 30 and 40%. Among more severely depressed support, mobilization of hope) are provided with pill patients antidepressants offer a clear advantage over placebo treatment. placebo; among less severely depressed patients and those The placebo response in depression has been viewed with a relatively short episode duration the placebo as a nuisance rather than as a therapeutic and research response rate is close to 50% and often indistinguishable opportunity. I propose that the initial treatment for from the response rate to antidepressants. In the selected depressed patients should be four to six weeks of treatment of depression none of the psychotherapies have placebo. Patients so treated should be informed that the consistently been shown to offer an advantage over pill placebo pill contains no drug but that this treatment can placebo. This is not entirely surprising given the fact that be helpful. [Neuropsychopharmacology 10:265-269, the common, and arguably the therapeutic, features of 1994J 1992; 1991). KEY WORDS: Placebo; Depression; Psychotherapy; C. Beasley, personal communication [One Antidepressant explanation for this apparent increase in the placebo response is that the relative paucity of side effects with I am proposing that the initial treatment for a sizable the newer drugs makes the results of placebo-controlled portion of depressed patients should be four to six studies less biased by knowledge of which patients are weeks of placebo.
    [Show full text]
  • Congressional Record United States Th of America PROCEEDINGS and DEBATES of the 104 CONGRESS, SECOND SESSION
    E PL UR UM IB N U U S Congressional Record United States th of America PROCEEDINGS AND DEBATES OF THE 104 CONGRESS, SECOND SESSION Vol. 142 WASHINGTON, WEDNESDAY, MAY 29, 1996 No. 76 Senate The Senate was not in session today. Its next meeting will be held on Monday, June 3, 1996, at 1:30 p.m. House of Representatives WEDNESDAY, MAY 29, 1996 The House met at 2 p.m. and was THE JOURNAL COMMUNICATION FROM THE called to order by the Speaker pro tem- The SPEAKER pro tempore. The CLERK OF THE HOUSE pore [Ms. GREENE of Utah]. Chair has examined the Journal of the The SPEAKER pro tempore laid be- f last day's proceedings and announces fore the House the following commu- to the House his approval thereof. nication from the Clerk of the House of Pursuant to clause 1, rule I, the Jour- Representatives: DESIGNATION OF THE SPEAKER nal stand as approved. PRO TEMPORE U.S. HOUSE OF REPRESENTATIVES, Mr. CHABOT. Madam Speaker, pur- Washington, DC, May 28, 1996. The SPEAKER pro tempore laid be- suant to clause 1, rule I, I demand a Hon. NEWT GINGRICH, fore the House the following commu- vote on agreeing to the Speaker's ap- The Speaker, U.S. House of Representatives, nication from the Speaker: proval of the Journal. Washington, DC. DEAR MR. SPEAKER: Pursuant to the per- WASHINGTON, DC, The SPEAKER pro tempore. The May 29, 1996. mission granted in Clause 5 of Rule III of the question is on the Chair's approval of Rules of the U.S.
    [Show full text]